Latest Financial Results
Q2 2022
Quarter Ended Jun 30, 2022
Latest Annual Report
View Annual ReportStock Information
Symbol
Nasdaq: BSGMPrice
Change
Volume
52 week Low/High
Day Low/High
Company Overview
BioSig Technologies is a medical device company commercializing a proprietary technology platform designed to improve the $8 billion electrophysiology (EP) marketplace. By 2028, the EP market is expected to reach $16 billion, with an estimated 11.2% CAGR.
Investor Relations
T: (203) 409-5444 x 133
info@biosigtech.com
Transfer Agent
Action Stock Transfer
Justeene Blankenship
2469 E. Fort Union Blvd
Suite 214
Salt Lake City, UT 84121
T: (801) 274-1088
action@actionstocktransfer.com
www.actionstocktransfer.com
